Israel Englander Xenon Pharmaceuticals Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 209,026 shares of XENE stock, worth $8.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209,026

Previous 175,584 19.05%

Holding current value

$8.22 Million

Previous $6.85 Million 20.14%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.12 - $43.96 $1.21 Million - $1.47 Million	33,442 Added 19.05%	209,026 $8.23 Million
Q2 2024 Aug 14, 2024	BUY	$36.25 - $43.75 $3.33 Million - $4.02 Million	91,923 Added 109.88%	175,584 $6.85 Million
Q1 2024 May 15, 2024	BUY	$42.66 - $50.04 $285,651 - $335,067	6,696 Added 8.7%	83,661 $3.6 Million
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $3.91 Million - $6.34 Million	-136,373 Reduced 63.92%	76,965 $3.55 Million
Q2 2023 Aug 14, 2023	SELL	$34.84 - $43.54 $283,318 - $354,067	-8,132 Reduced 3.67%	213,338 $8.21 Million
Q1 2023 May 15, 2023	SELL	$33.46 - $40.35 $12.5 Million - $15.1 Million	-373,071 Reduced 62.75%	221,470 $7.93 Million
Q4 2022 Feb 14, 2023	BUY	$33.06 - $39.43 $1.13 Million - $1.35 Million	34,192 Added 6.1%	594,541 $23.4 Million
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $2.08 Million - $2.69 Million	67,658 Added 13.73%	560,349 $20.2 Million
Q2 2022 Aug 15, 2022	BUY	$25.44 - $35.16 $9.07 Million - $12.5 Million	356,365 Added 261.41%	492,691 $15 Million
Q1 2022 May 16, 2022	BUY	$25.09 - $33.13 $1.15 Million - $1.51 Million	45,705 Added 50.44%	136,326 $4.17 Million
Q4 2021 Feb 14, 2022	SELL	$15.6 - $35.4 $2.27 Million - $5.15 Million	-145,598 Reduced 61.64%	90,621 $2.83 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $973,760 - $1.27 Million	-65,529 Reduced 21.72%	236,219 $3.61 Million
Q2 2021 Aug 16, 2021	SELL	$16.81 - $20.0 $691,748 - $823,020	-41,151 Reduced 12.0%	301,748 $5.62 Million
Q1 2021 May 17, 2021	SELL	$13.65 - $21.31 $1 Million - $1.57 Million	-73,576 Reduced 17.67%	342,899 $6.14 Million
Q4 2020 Feb 16, 2021	BUY	$9.49 - $16.04 $2.82 Million - $4.77 Million	297,630 Added 250.44%	416,475 $6.41 Million
Q3 2020 Nov 16, 2020	SELL	$10.82 - $13.35 $531,813 - $656,165	-49,151 Reduced 29.26%	118,845 $1.32 Million
Q2 2020 Aug 14, 2020	SELL	$10.21 - $14.9 $261,100 - $381,037	-25,573 Reduced 13.21%	167,996 $2.11 Million
Q1 2020 May 14, 2020	BUY	$8.08 - $17.57 $1.18 Million - $2.56 Million	145,855 Added 305.69%	193,569 $2.2 Million
Q4 2019 Feb 14, 2020	BUY	$8.11 - $14.65 $386,960 - $699,010	47,714 New	47,714 $626,000
Q2 2019 Aug 14, 2019	SELL	$8.51 - $10.75 $410,913 - $519,074	-48,286 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$6.39 - $10.42 $620,443 - $1.01 Million	-97,096 Reduced 66.79%	48,286 $491,000
Q4 2018 Feb 14, 2019	BUY	$5.61 - $12.62 $350,675 - $788,863	62,509 Added 75.43%	145,382 $917,000
Q3 2018 Nov 14, 2018	BUY	$9.0 - $14.9 $745,857 - $1.23 Million	82,873 New	82,873 $1.09 Million

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.45B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account